TIGIT and Huntington disease: Similarly, in B-cell chronic lymphocytic leukemia, Farhat et al. found an NK cell phenotype involving the coexpression of the potent inhibitory checkpoints PD-1 and TIGIT, which was not observed in NK cells from HD but constituted over 2% of the NK cells in many patients.